A recent study reported the mutation of an oligodendrocyte-related transcription factor TCF12 in 7.5% of anaplastic oligodendrogliomas: the mutations compromise TCF12 transcriptional activity and are associated with an aggressive tumor phenotype [148]. The gene discussed is TCF12; the disease is oligodendroglioma.